Edition:
India

Herbalife Ltd (HLF.N)

HLF.N on New York Stock Exchange

69.03USD
23 May 2017
Change (% chg)

$-4.41 (-6.00%)
Prev Close
$73.44
Open
$72.70
Day's High
$72.93
Day's Low
$67.79
Volume
699,595
Avg. Vol
214,596
52-wk High
$73.61
52-wk Low
$47.62

HLF.N

Chart for HLF.N

About

Herbalife Ltd. is a global nutrition company. The Company develops and sells weight management, healthy meals and snacks, sports and fitness, energy and targeted nutritional products, as well as personal care products. Its operating segments are based on geographical operations in six regions: North America; Mexico; South and... (more)

Overall

Beta: 1.64
Market Cap(Mil.): $5,873.69
Shares Outstanding(Mil.): 93.09
Dividend: --
Yield (%): --

Financials

  HLF.N Industry Sector
P/E (TTM): 20.94 67.65 41.43
EPS (TTM): 3.01 -- --
ROI: 16.11 6.09 62.63
ROE: 364.15 9.52 74.13

BRIEF-Herbalife CEO Michael Johnson engaged in net exercise transaction

* CEO Michael Johnson engaged in net exercise transaction involving 730,000 stock appreciation rights due to expire in Feb 2018 and Feb 2019 Source text for Eikon: Further company coverage:

20 May 2017

UPDATE 2-Herbalife CEO talks about obesity, vindication at Milken Conference

BEVERLY HILLS, Calif., May 3 After years of discord with a prominent hedge-fund manager, a federal investigation and bad publicity, Herbalife Ltd Chief Executive Officer Michael Johnson is taking a victory lap.

04 May 2017

Herbalife CEO Johnson talks obesity, 'fake news' at Milken Conference

BEVERLY HILLS, May 3 After years of discord with a prominent hedge-fund manager, a federal investigation and bad publicity, Herbalife Ltd Chief Executive Michael Johnson is taking a victory lap.

04 May 2017

BRIEF-Herbalife issues voluntary recall for peanut butter protein bar due to traces of fish allergen

* Herbalife International of America Inc issues voluntary recall for its protein bar - peanut butter due to trace amounts of undeclared fish allergen Source text for Eikon: Further company coverage:

03 May 2017

Senators press Icahn on White House influence, business conflicts

WASHINGTON Several Democratic senators pressed billionaire investor Carl Icahn on Monday to clarify his role as an adviser to President Donald Trump, saying his position in the administration raised "alarming" questions about potential conflicts of interest with his stakes in the biofuels and pharmaceutical industries.

28 Mar 2017

Senators press Icahn on White House influence, business conflicts

WASHINGTON, March 27 Several Democratic senators pressed billionaire investor Carl Icahn on Monday to clarify his role as an adviser to President Donald Trump, saying his position in the administration raised "alarming" questions about potential conflicts of interest with his stakes in the biofuels and pharmaceutical industries.

28 Mar 2017

U.S. Senate panel presses SEC nominee Clayton on conflicts

WASHINGTON Jay Clayton, the Wall Street attorney tapped by President Donald Trump to lead the U.S. Securities and Exchange Commission, on Thursday defended himself against Democrats' charges that multiple conflicts of interest would force him to miss too many SEC votes.

24 Mar 2017

UPDATE 4-U.S. Senate panel presses SEC nominee Clayton on conflicts

WASHINGTON, March 23 Jay Clayton, the Wall Street attorney tapped by President Donald Trump to lead the U.S. Securities and Exchange Commission, on Thursday defended himself against Democrats' charges that multiple conflicts of interest would force him to miss too many SEC votes.

24 Mar 2017

BRIEF-Herbalife CEO fy 2016 total compensation $10.9 mln - sec filing

* CEO Michael Johnson's fy 2016 total compensation $10.9 million versus $9.9 million in fy 2015 - SEC filing Source text for Eikon: Further company coverage:

14 Mar 2017

BRIEF-Carl Icahn reports purchase of 372,324 shares of Herbalife on Mar. 10 2017

* Carl Icahn reports purchase of 372,324 shares of Herbalife's common stock on March 10, 2017 at $51.35 per share - SEC filing Source text: (http://bit.ly/2n0phgW) Further company coverage:

13 Mar 2017

More From Around the Web

Earnings vs. Estimates